The lack of 4-hydroxynonenal in otosclerotic bone tissue in Ethiopian population

European Archives of Oto-Rhino-Laryngology

Volumn 272, Issue 10, 2015, Pages 2783-2789

  Rudic, Milan ^a   Wagner, Richard ^b   Willkinson, Eric ^b,c   Danese, Giovanni ^b,d   Kiros, Nega ^e   Zarkovic, Kamelija ^f   Zarkovic, Neven ^g  

^a GENERAL HOSPITAL ZADAR   (Croatia)

^b Global ENT Outreach   (United States)

^c HOUSE EAR INSTITUTE   (United States)

^d UNIVERSITY OF BERGAMO   (Italy)

^e Migbare Senay General Hospital   (Ethiopia)

^f KBC Zagreb   (Croatia)

^g RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Otosclerosis; Oxidative stress; Pathophysiology

Indexed keywords

4 HYDROXYNONENAL; FORMALDEHYDE; FREE RADICAL; PARAFFIN; 4-HYDROXY-2-NONENAL; ALDEHYDE;

ADULT; AGED; AIR CONDUCTION; ARTICLE; BONE GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ETHIOPIAN; FEMALE; HEARING IMPAIRMENT; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LIPID PEROXIDATION; MALE; MEDICAL SPECIALIST; MIDDLE AGED; OTOSCLEROSIS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; BONE; ETHIOPIA; INCIDENCE; METABOLISM; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ALDEHYDES; BONE AND BONES; ETHIOPIA; FEMALE; HUMANS; INCIDENCE; LIPID PEROXIDATION; MALE; MIDDLE AGED; OTOSCLEROSIS; OXIDATIVE STRESS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84940203724     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-014-3284-z     Document Type: Article

References (32)

1. Donaldson JA, Snyder M (1993) Otosclerosis. In: Cummings CW, Frederickson JM, Harker LA, Krause CJ, Schuller DE (eds) Otolaryngology-head and neck surgery. Mosby-Year Book, St Louis, pp 2997–3016
2. Liktor B, Csomor P, Karosi T (2013) Detection of otosclerosis-specific Measles Virus receptor (Cd46) protein isoforms. ISRN Otolaryngol
3. Declau F, van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, van de Heyning P (2007) Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians. Adv Otorhinolaryngol 67:6–16
4. Chole RA, McKenna M (2001) Pathophysiology of otosclerosis. Otol Neurotol 22:49–257
5. Grayeli AB, Sterkers O, Roulleau P, Elbaz P, Ferrary E, Silve C (1999) Parathyroid hormone-parathyroid hormone related peptide receptor expression and function in otosclerosis. Am J Physiol 277:E10005–E11012
6. Grayeli AB, Palmer P, Tran Ba Huy P, Soudant J, Sterkers O, Lebon P, Ferrary E (2000) No evidence of measles virus in stapes samples from patients with otosclerosis. J Clin Microbiol 38:2655–2660
7. Menger DJ, Tange RA (2003) The etiology of otosclerosis: a review of the literature. Clin Otolaryngol 28:112–120
8. Thys M, Van Camp G (2009) Genetics of otosclerosis. Otol Neurotol 30:101–1032
9. Topsakal V, Fransen E, Schmerber S, Declau F, Yung M, Gordts F, Van Camp G, Van de Heyning P (2006) Audiometrics analyses confirm a cochlear component, disproportional to age, in stapedial otosclerosis. Otol Neurotol 27:781–787
10. Imauchi Y, Lombes M, Laine P, Sterkers O, ferrary E, Grayeli AB (2006) Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6. Laryngoscope 116:1647–1650
11. Imauchi Y, Jeunemaitre X, Boussion M, Ferrary E, Sterkers O, Bozorg Grayeli A (2008) Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol 29:295–301
12. Rudić M, Nguyen C, Nguyen Y, Milković L, Zarković N, Sterkers O, Ferrary E, Bozorg Grayeli A (2012) Effects of angiotensin II on inflammation pathways in human primary bone cell cultures in otosclerosis. Audiol Neurootol 17:169–178
13. Lee SH, Goto T, Oe T (2008) A novel 4-oxo-2(E)-nonenal-derived modification to angiotensin II: oxidative decarboxylation of N-terminal aspartic acid. Chem Res Toxicol 21:2237–2244
14. Griendling KK, Ushio-Fukai M (2000) Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91:21–27
15. Rudić M, Milković L, Žarković K, Borović-Šunjić S, Sterkers O, Waeg G, Ferrary E, Bozorg Grayeli A, Žarković N (2013) The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis. Free Radic Biol Med 57:22–28
16. Ciorba A, Gasparini P, Chicca M, Pinamonti S, Martini A (2010) Reactive oxygen species in human inner ear perylimph. Acta Otolaryngol 130:240–246
17. Corbacella E, Lanzoni I, Ding D, Previati M, Salvi R (2004) Minocycline attenuates gentamicin in induced hair cell loss in neonatal cochlear culture. Hear Res 197:11–18
18. Wang J, Dib M, Lenoir M, Vago P, Eybalin M, Hameg A (2002) Riluzole rescues cochlear sensory cells from acoustic trauma in guinea pig. Neuroscience 111:635–648
19. Henderson D, Bielefeld EC, Harris KC, Hu BH (2006) The role of oxidative stress in noise- induced hearing loss. Ear Hear 27:1–19
20. Zarkovic N (2003) 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24:281–291
21. Borovic Sunjic S, Cipak A, Rabuzin F, Wildburger R, Zarkovic N (2005) The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. BioFactors 24:141–148
22. Borovic S, Cipak A, Mennitzer A, Kejla Z, Perovic D, Waeg G, Zarkovic N (2007) Differential sensitivity to 4-hydroxynonenal of normal and malignant mesenchymal cells. Redox Rep 12:50–54
23. Mrakovcic L, Wildburger R, Jaganjac M, Cindric M, Cipak A, Borovic-Sunjic S, Waeg G, Milankovic AM, Zarkovic N (2010) Lipid peroxidation product 4-hydroxynonenal as factor of oxidative homeostasis supporting bone regeneration with bioactive glasses. Acta Biochim Pol 57:173–178
24. Tomek MS, Brown MR, Mani SR, Ramesh A, Srisailapathy CR, Coucke P, Zbar RI, Bell AM, McGuirt WT, Fukushima K, Willems PJ, Van Camp G, Smith RJ (1998) Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum Mol Genet 7:285–290
25. Schrauwen I, Ealy M, Fransen E, Vanderstraeten K, Thys M, Meyer NC, Cosgaera M, Huber A, Mayzzoli M, Pfister M, Smith RJ, Van Camp G (2010) Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations. Hum Genet 127:155–162
26. Thys M, Schrauwen I, Vanderstraeten K, Dieltjens N, Fransen E, Ealy M, Cremers CWRJ, van de Heyning P, Vincent R, Offeciers E, Smith RH, van Camp G (2009) Detection of Rare Nonsynonymous Variants in TGFB1 in Otosclerosis Patients. Ann Hum Genet 73:171–175
27. Thys M, Schrauwen I, Vanderstraeten K, Janssens K, Dieltjens N, Van Den Bogaert Kris, Fransen E, Chen W, Ealy M, Claustres M, Cremers CRWJ, Dhooge I, Declau F, Claes J, Van de Heyning P, Vincent R, Somers T, Offeciers E, Smith RJH, Van Camp G (2007) The coding polymorphism T263I in TGF-b1 is associated with otosclerosis in two independent populations. Hum Mol Genet 16:2021–2030
28. Tshifularo M, Joseph CA (2008) Otosclerosis and TGF-β1 gene in black South Africans. South African Med J 98:720–723
29. Bodo M, Venti G, Baroni T, Bellucci C, Giammarioli M, Donti E, Paludetti G, Stabellini G, Carinci P (1995) Phenotype of in vitro human otosclerotic cells and its modulation by TGF beta. Cel Mol Biol 1995(41):1039–1049
30. Csomor P, Liktor B, Szekanecz Z, Sziklai I, Karosi T (2012) Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci. Acta Oto-Laryngol 132:624–631
31. Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G (2006) JNK up-regulation as a key event in the pro-apoptotic interaction between TGF-ß1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 40:443–454
32. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Manuel Otin P, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Richard RCM, Wiswedel I, Zarkovic K, Zarkovic N (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125–1171